Yoshino T - Search Results

1

A Learning Program for Treatment Recommendations by Molecular Tumor Boards and Artificial Intelligence.

Sunami K, Naito Y, Saigusa Y, Amano T, Ennishi D, Imai M, Kage H, Kanai M, Kenmotsu H, Komine K, Koyama T, Maeda T, Morita S, Sakai D, Hirata M, Ito M, Kozuki T, Sakashita H, Horinouchi H, Okuma Y, Takashima A, Kubo T, Hironaka S, Segawa Y, Yakushijin Y, Bando H, Makiyama A, Suzuki T, Kinoshita I, Kohsaka S, Ohe Y, Ishioka C, Yamamoto K, Tsuchihara K, Yoshino T. Sunami K, et al. Among authors: yoshino t. JAMA Oncol. 2024 Jan 1;10(1):95-102. doi: 10.1001/jamaoncol.2023.5120. JAMA Oncol. 2024. PMID: 38032680 Free PMC article.

2

Small cell carcinoma of the esophagus responding to fourth-line chemotherapy with weekly paclitaxel.

Matsuoka M, Boku N, Yoshino T, Hironaka S, Onozawa Y, Fukutomi A, Zenda S, Yamazaki K, Yasui H, Hasuike N, Inui T, Yamaguchi Y, Ono H, Kamata M. Matsuoka M, et al. Among authors: yoshino t. Int J Clin Oncol. 2005 Dec;10(6):429-32. doi: 10.1007/s10147-005-0502-0. Int J Clin Oncol. 2005. PMID: 16369748

3

Weekly paclitaxel as second-line chemotherapy for advanced or recurrent gastric cancer.

Hironaka S, Zenda S, Boku N, Fukutomi A, Yoshino T, Onozawa Y. Hironaka S, et al. Among authors: yoshino t. Gastric Cancer. 2006;9(1):14-8. doi: 10.1007/s10120-005-0351-6. Gastric Cancer. 2006. PMID: 16557431

4

Combination chemotherapy with irinotecan and cisplatin in pretreated patients with unresectable or recurrent gastric cancer.

Ueda S, Hironaka S, Boku N, Fukutomi A, Yoshino T, Onozawa Y. Ueda S, et al. Among authors: yoshino t. Gastric Cancer. 2006;9(3):203-7. doi: 10.1007/s10120-006-0379-2. Gastric Cancer. 2006. PMID: 16952039

5

Efficacy and safety of an irinotecan plus bolus 5-fluorouracil and L-leucovorin regimen for metastatic colorectal cancer in Japanese patients: experience in a single institution in Japan.

Yoshino T, Boku N, Onozawa Y, Hironaka S, Fukutomi A, Yamaguchi Y, Hasuike N, Yamazaki K, Machida N, Ono H. Yoshino T, et al. Jpn J Clin Oncol. 2007 Sep;37(9):686-91. doi: 10.1093/jjco/hym091. Epub 2007 Aug 24. Jpn J Clin Oncol. 2007. PMID: 17720736

6

A retrospective study of second-line chemotherapy for unresectable or recurrent squamous cell carcinoma of the esophagus refractory to chemotherapy with 5-fluorouracil plus platinum.

Yamazaki K, Hironaka S, Boku N, Yasui H, Fukutomi A, Yoshino T, Onozawa Y, Hasuike N, Inui T, Yamaguchi Y, Ono H. Yamazaki K, et al. Among authors: yoshino t. Int J Clin Oncol. 2008 Apr;13(2):150-5. doi: 10.1007/s10147-007-0738-y. Epub 2008 May 8. Int J Clin Oncol. 2008. PMID: 18463960

7

Impact of baseline sum of longest diameter in target lesions by RECIST on survival of patients with metastatic colorectal cancer.

Machida N, Yoshino T, Boku N, Hironaka S, Onozawa Y, Fukutomi A, Yamazaki K, Yasui H, Taku K, Asaka M. Machida N, et al. Among authors: yoshino t. Jpn J Clin Oncol. 2008 Oct;38(10):689-94. doi: 10.1093/jjco/hyn086. Jpn J Clin Oncol. 2008. PMID: 18845522

8

Results of a retrospective analysis of gemcitabine as a second-line treatment after chemoradiotherapy and maintenance chemotherapy using 5-fluorouracil in patients with locally advanced pancreatic cancer.

Taira K, Boku N, Fukutomi A, Onozawa Y, Hironaka S, Yoshino T, Yasui H, Yamazaki K, Taku K, Hashimoto T, Nishimura T. Taira K, et al. Among authors: yoshino t. J Gastroenterol. 2008;43(11):875-80. doi: 10.1007/s00535-008-2236-z. Epub 2008 Nov 18. J Gastroenterol. 2008. PMID: 19012041

9

Activity of S-1 in advanced or recurrent gastric cancer patients after failure of prior chemotherapy, including irinotecan + cisplatin or fluorouracil (except S-1).

Ono A, Boku N, Onozawa Y, Hironaka S, Fukutomi A, Yasui H, Yamazaki K, Yoshino T, Taku K, Kojima T. Ono A, et al. Among authors: yoshino t. Jpn J Clin Oncol. 2009 May;39(5):332-5. doi: 10.1093/jjco/hyp018. Epub 2009 Mar 24. Jpn J Clin Oncol. 2009. PMID: 19318372

10

Feasibility and robustness of amplification refractory mutation system (ARMS)-based KRAS testing using clinically available formalin-fixed, paraffin-embedded samples of colorectal cancers.

Ogasawara N, Bando H, Kawamoto Y, Yoshino T, Tsuchihara K, Ohtsu A, Esumi H. Ogasawara N, et al. Among authors: yoshino t. Jpn J Clin Oncol. 2011 Jan;41(1):52-6. doi: 10.1093/jjco/hyq151. Epub 2010 Aug 9. Jpn J Clin Oncol. 2011. PMID: 20696815

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

2,053 results

Search Page